BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30939155)

  • 1. Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.
    Bintener T; Pacheco MP; Philippidou D; Margue C; Kishk A; Del Mistro G; Di Leo L; Moscardó Garcia M; Halder R; Sinkkonen L; De Zio D; Kreis S; Kulms D; Sauter T
    Cell Death Dis; 2023 Jul; 14(7):468. PubMed ID: 37495601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.
    Psilopatis I; Garmpis N; Garmpi A; Vrettou K; Sarantis P; Koustas E; Antoniou EA; Dimitroulis D; Kouraklis G; Karamouzis MV; Marinos G; Kontzoglou K; Nonni A; Nikolettos K; Fleckenstein FN; Zoumpouli C; Damaskos C
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.
    Al-Wahaibi LH; Al-Saleem MSM; Ahmed OAA; Fahmy UA; Alhakamy NA; Eid BG; Abdel-Naim AB; Abdel-Mageed WM; AlRasheed MM; Shazly GA
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Cyclin Dependent Kinase Inhibitor p21
    Al Bitar S; Gali-Muhtasib H
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31575057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant cell cycle regulation in cervical carcinoma.
    Kim YT; Zhao M
    Yonsei Med J; 2005 Oct; 46(5):597-613. PubMed ID: 16259056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21 in Cancer Research.
    Shamloo B; Usluer S
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms of fluvastatin and lovastatin for the p21 induction in human cervical cancer HeLa cells.
    Lin CK; Liu ST; Chang CC; Huang SM
    PLoS One; 2019; 14(4):e0214408. PubMed ID: 30939155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
    Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer.
    Chen C; Wu H; Kong D; Xu Y; Zhang Z; Chen F; Zou L; Li Z; Shui J; Luo H; Liu SH; Yu J; Wang K; Brunicardi FC
    Oncol Rep; 2020 Dec; 44(6):2569-2580. PubMed ID: 33125137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
    Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
    Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.
    Hao ZF; Su YM; Wang CM; Yang RY
    Tumour Biol; 2015 Mar; 36(3):1471-6. PubMed ID: 25371069
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.